Paxlovid for uremia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 May 2022: Trial registered, NCT05386433

The trials

NCT05386433: Paxlovid in the Treatment of COVID-19 Patients With Uremia

State
State not given
Phase
Early Phase 1
People
40 planned
Started
Jun 2022
Primary completion
Jul 2022
Arms
standard-of-care plus Paxlovid
Results
None posted
  1. 23 May 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.